 {"id":15058,"date":"2026-08-12T03:09:36","date_gmt":"2026-08-12T10:09:36","guid":{"rendered":"https:\/\/cellpeptides.com\/?post_type=product&#038;p=15058"},"modified":"2026-08-12T03:25:58","modified_gmt":"2026-08-12T10:25:58","slug":"buy-foxo4-dri-2mg","status":"publish","type":"product","link":"https:\/\/cellpeptides.com\/sk\/product\/buy-foxo4-dri-2mg\/","title":{"rendered":"FOXO4-DRI 2 mg"},"content":{"rendered":"<h2><span style=\"font-weight: 400;\">FOXO4-DRI je experiment\u00e1lny peptid, ktor\u00fd bol vyvinut\u00fd na \u0161t\u00fadium a potenci\u00e1lne spomalenie procesu starnutia. Je navrhnut\u00fd tak, aby interferoval s interakciou medzi prote\u00ednom FOXO4 a p53, \u010do pom\u00e1ha indukova\u0165 apopt\u00f3zu (programovan\u00fa bunkov\u00fa smr\u0165) v senescentn\u00fdch (starn\u00facich) bunk\u00e1ch, ktor\u00e9 sa prestali deli\u0165, ale neodumreli. Tieto bunky sa \u010dasto naz\u00fdvaj\u00fa \"zombie bunky\" a prispievaj\u00fa k starnutiu tkan\u00edv a r\u00f4znym vekom podmienen\u00fdm ochoreniam.<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Toto je syntetick\u00fd peptid tvoren\u00fd 46 aminokyselinami, zlo\u017een\u00fd v\u00fdlu\u010dne z D-aminokysel\u00edn v opa\u010dnom porad\u00ed. Dod\u00e1va sa ako lyofilizovan\u00fd pr\u00e1\u0161ok na laborat\u00f3rne a v\u00fdskumn\u00e9 \u00fa\u010dely. <\/span><i><span style=\"font-weight: 400;\">iba<\/span><\/i><span style=\"font-weight: 400;\">. Predov\u0161etk\u00fdm sa tento peptid sk\u00fama kv\u00f4li selekt\u00edvnemu odstra\u0148ovaniu senescentn\u00fdch buniek, preto\u017ee dok\u00e1\u017ee preru\u0161i\u0165 v\u00e4zbu s p53 v starn\u00facich bunk\u00e1ch, \u010d\u00edm ich nech\u00e1 zomrie\u0165. Majte v\u0161ak na pam\u00e4ti, \u017ee FOXO4-DRI je zatia\u013e len v \u0161t\u00e1diu predklinick\u00fdch testov a neexistuj\u00fa o \u0148om \u017eiadne \u00fadaje u \u013eud\u00ed. V\u00e4\u010d\u0161ina prehnan\u00fdch tvrden\u00ed o starnut\u00ed a zab\u00edjan\u00ed \u201czombie buniek\u201d je trochu ved\u013ea. K\u013e\u00fa\u010dov\u00fdm zisten\u00edm z jeho aplik\u00e1cie u my\u0161\u00ed bolo, \u017ee obnovil kond\u00edciu, hustotu ssrsti a obli\u010dkov\u00e9 funkcie u r\u00fdchlo starn\u00facich my\u0161\u00ed XpdTTD\/TTD, ako aj u prirodzene starn\u00facich my\u0161\u00ed. \u017diadna \u0161t\u00fadia ho nespom\u00edna ako nie\u010do, \u010do \u201cvracia starnutie sp\u00e4\u0165\u201d.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400;\">DRI znamen\u00e1 D-retro-inverso. V podstate to znamen\u00e1 obr\u00e1ten\u00fa sekvenciu alebo zrkadlov\u00fd obraz aminokysel\u00edn. Vedci takto ot\u00e1\u010daj\u00fa sekvencie preto, lebo hoci celkov\u00fd \u00fa\u010dinok zostane rovnak\u00fd, degrad\u00e1cia sa v\u00fdrazne spomal\u00ed. In\u00fdmi slovami, peptidy zlo\u017een\u00e9 z L-aminokysel\u00edn prote\u00e1zy r\u00fdchlo rozlo\u017eia, zatia\u013e \u010do t\u00e1to taktika so zrkadlov\u00fdm obrazom a obr\u00e1tenou sekvenciou zachov\u00e1 topol\u00f3giu postrann\u00fdch re\u0165azcov (tak\u017ee sa st\u00e1le m\u00f4\u017ee norm\u00e1lne viaza\u0165) a z\u00e1rove\u0148 odol\u00e1va degrad\u00e1cii.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Interak\u010dn\u00e1 oblas\u0165 prote\u00ednu FOXO4 s p53 bola \u0161tudovan\u00e1 a variant DRI tohto peptidu odvodili Baar a kolegovia v laborat\u00f3riu de Keizer (Cell, 2017). Peptid m\u00e1 bunkovo-penetra\u010dn\u00fd chvost, ktor\u00fd mu umo\u017e\u0148uje prech\u00e1dza\u0165 cez bunkov\u00e9 membr\u00e1ny.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Ako funguje FOXO4-DRI?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Ve\u013ea z toho, ako peptidom funguje, z\u00e1vis\u00ed od receptorov. A tak je to aj v tomto pr\u00edpade. Po\u010fme sa v\u0161ak najprv vr\u00e1ti\u0165 o krok sp\u00e4\u0165.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Starn\u00face bunky sa naz\u00fdvaj\u00fa senescentn\u00e9 bunky. Tieto bunky sa prestali deli\u0165, s\u00fa ve\u013ek\u00e9 a \u010dasto m\u00f4\u017eu uvo\u013e\u0148ova\u0165 \u0161kodliv\u00e9 z\u00e1palov\u00e9 chemik\u00e1lie a dokonca po\u0161kodzova\u0165 okolit\u00e9 tkaniv\u00e1. V t\u00fdchto bunk\u00e1ch sa hromad\u00ed prote\u00edn naz\u00fdvan\u00fd FOXO4. Navy\u0161e, ke\u010f bunky podst\u00fapia senescenciu vyvolan\u00fa \u017eiaren\u00edm (napr\u00edklad po\u010das chemoterapie), hromad\u00ed sa v nich ve\u013ek\u00e9 mno\u017estvo FOXO4. \u00dalohou FOXO4 je zabr\u00e1ni\u0165 apopt\u00f3ze v t\u00fdchto senescentn\u00fdch bunk\u00e1ch. Ak by ste dok\u00e1zali potla\u010di\u0165 expresiu FOXO4, prirodzene by ste zaznamenali \u00fahyn v\u00e4\u010d\u0161ieho mno\u017estva t\u00fdchto senescentn\u00fdch buniek.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">To, \u010do FOXO4 rob\u00ed v starn\u00facej bunke, je, \u017ee dr\u017e\u00ed p53 \u2013 prote\u00edn, ktor\u00fd m\u00e1 mnoho \u00faloh, pri\u010dom jednou z nich je vysiela\u0165 sign\u00e1ly smeruj\u00face k smrti, aby bunka mohla zomrie\u0165. K\u00fdm mno\u017estvo FOXO4 dr\u017e\u00ed v\u0161etok tento p53 v senescentn\u00fdch bunk\u00e1ch, ty nezomr\u00fa.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Syntetick\u00fd peptid FOXO4-DRI, o ktorom tu hovor\u00edme, s\u00fa\u0165a\u017e\u00ed o v\u00e4zbov\u00e9 miesto. Sna\u017e\u00ed sa naviaza\u0165 na p53 sk\u00f4r, ne\u017e tak urob\u00ed samotn\u00fd bunkov\u00fd prote\u00edn FOXO4. A je v tom celkom \u00faspe\u0161n\u00fd. Zistilo sa, \u017ee tento peptid m\u00e1 vy\u0161\u0161iu afinitu k p53. Ke\u010f\u017ee sme nahradili prirodzen\u00fa v\u00e4zbu FOXO4\/p53 v\u00e4zbou FOXO4-DRI\/p53, v podstate sme zabr\u00e1nili tomu, aby bol p53 viazan\u00fd v jadre. M\u00f4\u017ee sa presun\u00fa\u0165 von a vysiela\u0165 sign\u00e1ly ved\u00face k smrti bunky, preto\u017ee peptid FOXO4-DRI tomu nebr\u00e1ni.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">T\u00fdm, \u017ee sa peptid navia\u017ee na p53 sk\u00f4r, ne\u017e to dok\u00e1\u017ee prirodzen\u00fd FOXO4, umo\u017e\u0148uje starn\u00facim bunk\u00e1m zomrie\u0165. Ke\u010f\u017ee p nie je naviazan\u00fd na prirodzen\u00fd FOXO4 (ktor\u00fd ho dr\u017e\u00ed v jadre), presunie sa do mitochondri\u00ed a spust\u00ed apopt\u00f3zu. To n\u00e1sledne \u00faplne eliminuje senescentn\u00fa bunku.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tento peptid je zo svojej podstaty selekt\u00edvny, preto\u017ee samotn\u00fd prote\u00edn FOXO4 sa v preva\u017enej v\u00e4\u010d\u0161ine zdrav\u00fdch dospel\u00fdch buniek vyskytuje v n\u00edzkom mno\u017estve. Zv\u00fd\u0161en\u00fd je len v senescentn\u00fdch bunk\u00e1ch.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Interakcia FOXO4-p53<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Pre\u010do po\u0161koden\u00e9 bunky odmietnu zomrie\u0165? Hromadiace sa po\u0161kodenie DNA za norm\u00e1lnych okolnost\u00ed tla\u010d\u00ed bunku bu\u010f k apopt\u00f3ze, alebo k senescencii. Senescentn\u00e9 bunky urobili t\u00fato druh\u00fa vo\u013ebu a musia toto rozhodnutie neust\u00e1le obhajova\u0165, tak\u017ee \u017eij\u00fa \u010falej. Inak povedan\u00e9, ide o rezistenciu vo\u010di apopt\u00f3ze. T\u00e1to rezistencia vznik\u00e1 prostredn\u00edctvom mnoh\u00fdch faktorov. S\u00fa pripraven\u00e9 zomrie\u0165, ale st\u00e1le sa dr\u017eia. Sekvestr\u00e1cia p53 prote\u00ednom FOXO4 je jedn\u00fdm z mechanizmov, ktor\u00e9 toto zotrv\u00e1vanie zabezpe\u010duj\u00fa.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Prirodzene sa zistilo, \u017ee FOXO4 je zv\u00fd\u0161en\u00fd v senescentn\u00fdch bunk\u00e1ch a je k\u013e\u00fa\u010dovou zlo\u017ekou udr\u017eiavania \u017eivotaschopnosti buniek. Dr\u017e\u00ed p53 v jadre, ktor\u00fd by inak vyslal sign\u00e1l na apopt\u00f3zu.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">FOXO4-DRI a senescentn\u00e9 bunky: Na \u010do sa pou\u017e\u00edva?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Senescencia je stav, v ktorom sa bunka nach\u00e1dza v stave trval\u00e9ho zastavenia. Bunka je pripraven\u00e1 na smr\u0165, ale dr\u017e\u00ed sa \u2013 zost\u00e1va metabolicky akt\u00edvna a taktie\u017e sekretuje. Tieto bunky vytv\u00e1raj\u00fa sekretorick\u00fd fenotyp asociovan\u00fd so senescenciou, pretrv\u00e1vaj\u00faci proz\u00e1palov\u00fd fenotyp, ktor\u00fd m\u00f4\u017ee prispieva\u0165 k zr\u00fdchlen\u00e9mu starnutiu a chemotoxicite.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Pr\u00e1ce od roku 2011 uk\u00e1zali, \u017ee odstr\u00e1nenie senescentn\u00fdch buniek m\u00f4\u017ee zabr\u00e1ni\u0165 dysfunkcii tkaniva alebo ju oddiali\u0165 a \u017ee senescentn\u00e9 bunky zaberaj\u00fa miesto zdrav\u00fdch buniek a zhor\u0161uj\u00fa lok\u00e1lnu funkciu, ak nie s\u00fa odstr\u00e1nen\u00e9. Pre\u010do k tomu vlastne doch\u00e1dza? Senescencia toti\u017e nie je jednotne zl\u00e1. Bunkov\u00e1 senescencia m\u00e1 dvojak\u00fa povahu \u2013 v skuto\u010dnosti je prospe\u0161n\u00e1 po\u010das embryon\u00e1lneho v\u00fdvoja, opravy tkan\u00edv a potl\u00e1\u010dania n\u00e1dorov. Je v\u0161ak \u0161kodliv\u00e1 pri chronickom strese, pretrv\u00e1vaj\u00facom poranen\u00ed tkaniva a zhor\u0161enom \u010disten\u00ed.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">V\u00fdskum bunkov\u00e9ho starnutia<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">FOXO4-DRI sa sk\u00fama najm\u00e4 ako experiment\u00e1lny senolytick\u00fd peptid, ktor\u00fd sa odli\u0161uje od malomolekulov\u00fdch senolyt\u00edk. P\u00f4vodn\u00fd in-vitro model vyu\u017e\u00edval \u013eudsk\u00e9 fibroblasty IMR90 so senescenciou indukovanou ionizuj\u00facim \u017eiaren\u00edm. K\u013e\u00fa\u010dov\u00fd v\u00fdsledok? Vynikaj\u00faca selektivita. Mnoho neskor\u0161\u00edch v\u00fdskumn\u00fdch skup\u00edn navy\u0161e tento peptid pou\u017eilo ako sondu naprie\u010d r\u00f4znymi typmi buniek, od fibroblastov IMR90 a Leydigov\u00fdch buniek TM3 a\u017e po chondrocyty, endotelov\u00e9 bunky a p\u013e\u00facne fibroblasty.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">V\u00fdskum funkci\u00ed s\u00favisiacich s vekom<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">\u0160t\u00fadie na zvierat\u00e1ch uk\u00e1zali zlep\u0161enie fyzickej aktivity, stavu srsti, obli\u010dkov\u00fdch markerov a funkcie tkan\u00edv. V p\u00f4vodnej pr\u00e1ci sa nach\u00e1dzaj\u00fa dva k\u013e\u00fa\u010dov\u00e9 modely: r\u00fdchlo starn\u00faci kme\u0148 s deficienciou opravy DNA a prirodzene starn\u00face my\u0161i. V\u00fdsledky boli konzistentn\u00e9 u oboch. Aktivita na be\u017eeckom kolese a sk\u00f3re srsti sa hodnotili u 26-t\u00fd\u017ed\u0148ov\u00fdch my\u0161\u00ed divok\u00e9ho typu a XpdTTD\/TTD, pri\u010dom zabehnut\u00e1 vzdialenos\u0165 sa meria v km za de\u0148. \u0160t\u00fadia taktie\u017e informovala o zn\u00ed\u017eenom v\u00fdskyte spont\u00e1nne vznikaj\u00facej ren\u00e1lnej glomeruloskler\u00f3zy a zlep\u0161enej filtra\u010dnej schopnosti obli\u010diek u r\u00fdchlo starn\u00facich my\u0161\u00ed.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">V\u00fdskum reproduk\u010dn\u00e9ho starnutia<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Uskuto\u010dnili sa dve samostatn\u00e9 \u010d\u00ednske \u0161t\u00fadie od tej istej skupiny. V prvej (Zhang et al. 2020) zlep\u0161en\u00e9 markery preuk\u00e1zali zv\u00fd\u0161en\u00fd s\u00e9rov\u00fd testoster\u00f3n, zv\u00fd\u0161en\u00e9 3\u03b2-HSD a CYP11A1, zn\u00ed\u017een\u00fa interstici\u00e1lnu aktivitu SA-\u03b2-gal, ni\u017e\u0161ie p53, p21 a p16 a zn\u00ed\u017een\u00e9 IL-1\u03b2, IL-6 a TGF-\u03b2. Druh\u00e1 \u0161t\u00fadia (Li et al. 2024) mala in\u00fd dizajn a dlh\u0161iu expoz\u00edciu. Uv\u00e1dzan\u00fdm v\u00fdsledkom bola zv\u00fd\u0161en\u00e1 kvalita spermi\u00ed a zlep\u0161en\u00e1 spermatogen\u00e9za u lie\u010den\u00fdch star\u00fdch my\u0161\u00ed, pri\u010dom navrhovan\u00fdm mechanizmom bola zn\u00ed\u017een\u00e1 sekr\u00e9cia SASP z Leydigov\u00fdch buniek.\u00a0<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">V\u00fdskum fibr\u00f3zy a tkan\u00edv<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">V\u00fdskumn\u00edci tie\u017e sk\u00famali FOXO4-DRI v experiment\u00e1lnych modeloch p\u013e\u00facnej fibr\u00f3zy, chrupaviek a starnutia ciev.<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>P\u013e\u00facna fibr\u00f3za<\/b><span style=\"font-weight: 400;\">V my\u0161om modeli p\u013e\u00facnej fibr\u00f3zy indukovanej bleomyc\u00ednom FOXO4-DRI zn\u00ed\u017eil po\u010det senescentn\u00fdch buniek, zn\u00ed\u017eil expresiu SASP a zmiernil morfologick\u00e9 zmeny a ukladanie kolag\u00e9nu indukovan\u00e9 bleomyc\u00ednom, \u010do je porovnate\u013en\u00e9 so schv\u00e1len\u00fdm liekom pirfenid\u00f3n; taktie\u017e zv\u00fd\u0161il percento alveol\u00e1rnych epitelov\u00fdch buniek 2. typu a fibroblastov a s\u00fa\u010dasne zn\u00ed\u017eil po\u010det myofibroblastov a in vitro preuk\u00e1zal tendenciu usmrcova\u0165 myofibroblasty indukovan\u00e9 TGF-\u03b2<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Chrupavka<\/b><span style=\"font-weight: 400;\">\u013dudsk\u00e9 chondrocyty boli namno\u017een\u00e9 na \u00farove\u0148 zdvojn\u00e1sobenia popul\u00e1cie 9 na simul\u00e1ciu buniek pripraven\u00fdch na autol\u00f3gnu implant\u00e1ciu chondrocytov, pri\u010dom PDL3 sl\u00fa\u017eilo ako minim\u00e1lne namno\u017een\u00e1 kontrola. L\u00e1tka FOXO4-DRI odstr\u00e1nila viac ako polovicu buniek PDL9 bez v\u00fdznamn\u00e9ho ovplyvnenia po\u010dtu buniek PDL3 a v\u00fdrazne zn\u00ed\u017eila \u00farove\u0148 senescencie v PDL9. Predbe\u017en\u00e1 lie\u010dba nezv\u00fd\u0161ila chondrog\u00e9nny potenci\u00e1l chondrocytov PDL9, hoci chrupavka vytvoren\u00e1 z vopred o\u0161etren\u00fdch buniek vykazovala ni\u017e\u0161iu expresiu sekretorick\u00fdch faktorov s\u00favisiacich so senescenciou.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Vaskul\u00e1rne starnutie<\/b><span style=\"font-weight: 400;\">Toto je najnov\u0161ia pr\u00e1ca. \u0160t\u00fadia z roku 2026 uv\u00e1dza, \u017ee FOXO4-DRI indukuje apopt\u00f3zu v senescentn\u00fdch endotelov\u00fdch bunk\u00e1ch aktiv\u00e1ciou dr\u00e1hy p53\/BCL-2\/Caspase-3 a zlep\u0161uje cievne funkcie a z\u00e1rove\u0148 od\u010fa\u013euje starnutie ciev<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">FOXO4-DRI vs. in\u00e9 senolytik\u00e1<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Neexistuje \u017eiadna priama \u201calternat\u00edva\u201d, ale nieko\u013eko r\u00f4znych mechanizmov p\u00f4sob\u00ed na r\u00f4zne anti-apoptotick\u00e9 dr\u00e1hy senescentn\u00fdch buniek, ktor\u00e9 mo\u017eno zhruba porovna\u0165. Okrem toho majte na pam\u00e4ti, \u017ee r\u00f4zne typy senescentn\u00fdch buniek reaguj\u00fa na r\u00f4zne l\u00e1tky. Preto nie s\u00fa vz\u00e1jomne zamenn\u00e9. \u017diadna z nich nie je vo svojej podstate lep\u0161ia.<\/span><\/p>\n<table>\n<tbody>\n<tr>\n<td><\/td>\n<td><b>FOXO4-DRI<\/b><\/td>\n<td><b>Dasatinib + Quercet\u00edn<\/b><\/td>\n<td><b>Fisetin<\/b><\/td>\n<\/tr>\n<tr>\n<td><b>Trieda<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Syntetick\u00fd D-retro-inverzn\u00fd peptid<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Inhib\u00edtor kin\u00e1zy plus flavonoid, peror\u00e1lne<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Flavonoid, peror\u00e1lny<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Mechanizmus<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Naru\u0161uje jednu konkr\u00e9tnu interakciu medzi prote\u00ednmi (FOXO4-p53)<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Do\u010dasne deaktivuje siete na pre\u017eitie chr\u00e1niace senescentn\u00e9 bunky<\/span><\/td>\n<td><span style=\"font-weight: 400;\">\u0160irok\u00e1 senolytick\u00e1 aktivita flavonoidov<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>Doru\u010denie<\/b><\/td>\n<td><span style=\"font-weight: 400;\">Injek\u010dn\u00fd pr\u00edpravok v \u0161t\u00fadi\u00e1ch na zvierat\u00e1ch<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Or\u00e1lny<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Or\u00e1lny<\/span><\/td>\n<\/tr>\n<tr>\n<td><b>\u013dudsk\u00e9 \u00fadaje<\/b><\/td>\n<td><span style=\"font-weight: 400;\">\u017diadne<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Pilotn\u00e9 \u0161t\u00fadie v po\u010diato\u010dnej f\u00e1ze<\/span><\/td>\n<td><span style=\"font-weight: 400;\">Prebiehaj\u00face klinick\u00e9 sk\u00fa\u0161ky<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">D\u00e1vkovacie protokoly FOXO4-DRI vo v\u00fdskume vs. biohacking a spr\u00e1vy na Reddite<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">\u00dadaje uveden\u00e9 ni\u017e\u0161ie s\u00fa parametre pre zvierat\u00e1 a bunkov\u00e9 kult\u00fary zaznamenan\u00e9 na zaistenie reprodukovate\u013enosti v laborat\u00f3rnych podmienkach. Neexistuje \u017eiadna stanoven\u00e1 d\u00e1vka pre \u013eud\u00ed, \u017eiadne \u00fadaje o bezpe\u010dnosti pre \u013eud\u00ed, \u017eiadne \u00fadaje o \u00fa\u010dinnosti u \u013eud\u00ed a \u017eiaden overen\u00fd sp\u00f4sob, ako prepo\u010d\u00edta\u0165 hodnotu v mg\/kg pre zvierat\u00e1 na hodnotu pre \u010dloveka.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Publikovan\u00e9 v\u00fdskumn\u00e9 protokoly<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Preru\u0161ovan\u00e9 d\u00e1vkovanie v kr\u00e1tkych cykloch je v odbornej literat\u00fare normou a pre tento peptid nebola publikovan\u00e1 \u017eiadna \u0161t\u00fadia zameran\u00e1 na vz\u0165ah medzi d\u00e1vkou a odpove\u010fou ani na optimaliz\u00e1ciu d\u00e1vkovania. Tu s\u00fa \u0161t\u00fadie a d\u00e1vkovanie, ktor\u00e9 pou\u017eili:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Baar a kol. 2027, Cell: O\u017eiaren\u00e9 fibroblasty IMR90 in vitro, my\u0161i lie\u010den\u00e9 doxorubic\u00ednom, r\u00fdchlo starn\u00face my\u0161i XpdTTD\/TTD, prirodzene starn\u00face my\u0161i. 4 a\u017e 5 divok\u00fdch typov alebo my\u0161\u00ed XpdTTD\/TTD lie\u010den\u00fdch v 0., 2. a 4. dni d\u00e1vkou 5 mg\/kg FOXO4-DRI intraven\u00f3znou injekciou, pri\u010dom vzorka krvi bola odobrat\u00e1 28 dn\u00ed po prvej injekcii, a v ramene chemotoxicity bola podan\u00e1 jednorazov\u00e1 d\u00e1vka doxorubic\u00ednu 10 mg\/kg i.p. nasledovan\u00e1 FOXO4-DRI v d\u00e1vke 4 x 10 mg\/kg i.v., plus druh\u00fd experiment s pou\u017eit\u00edm dvoch d\u00e1vok doxorubic\u00ednu nasledovan\u00fdch FOXO4-DRI v d\u00e1vke 3 x 5 mg\/kg s odstupom jedn\u00e9ho d\u0148a.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Zhang a kol. 2020, Aging: Prirodzene starn\u00face 20 a\u017e 24 mesiacov star\u00e9 my\u0161i, 5 mg\/kg v PBS, intraperitone\u00e1lne, ka\u017ed\u00fd druh\u00fd de\u0148, tri podania.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Huang et al. 2021, Front Bioeng Biotechnol.: Iba in vitro, \u013eudsk\u00e9 chondrocyty pri PDL9 oproti PDL3.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Han et al. 2022, J Cell Mol Med.: Samce my\u0161\u00ed C57BL\/6J vo veku 6 a\u017e 8 t\u00fd\u017ed\u0148ov, peptid zrieden\u00fd na 1 mg\/ml v PBS pred intraperitone\u00e1lnou injekciou.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Li a kol. 2024, Exp Gerontol.: 20-mesa\u010dn\u00e9 my\u0161i, 5 mg\/kg\/de\u0148 intraperitone\u00e1lne po\u010das 30 dn\u00ed.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Hu a kol. 2026, Front Bioeng Biotechnol.: 17-mesiacov\u00e9 my\u0161i, 5 mg\/kg intraperitone\u00e1lne ka\u017ed\u00e9 2 dni po\u010das 1 mesiaca.<\/span><\/li>\n<\/ul>\n<h3><span style=\"font-weight: 400;\">Biohacking a spr\u00e1vy z Redditu<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">O tomto peptide sa ur\u010dite diskutuje, ale ni\u010d z nasleduj\u00faceho nemo\u017eno reprodukova\u0165 ako protokol. Na f\u00f3rach a blogoch predajcov koluje mno\u017estvo spr\u00e1v o sebaexperimentovan\u00ed, pri\u010dom v\u0161etky s\u00fa nekontrolovan\u00e9 a zalo\u017een\u00e9 na vlastn\u00fdch tvrdeniach. V \u017eiadnom z nich neexistuje nez\u00e1visl\u00e9 overenie toto\u017enosti zl\u00fa\u010deniny, \u010distoty ani v\u00fdsledku.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tie\u017e ide o prepo\u010dty d\u00e1vky pre my\u0161 na z\u00e1klade telesnej hmotnosti bez medzidruhov\u00e9ho prepo\u010d\u00edtavacieho faktora, bez farmakokinetick\u00fdch \u00fadajov a bez toxikol\u00f3gie.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">V\u0161eobecne plat\u00ed, \u017ee mnoh\u00e9 osobnosti soci\u00e1lnych m\u00e9di\u00ed a subreddity ako r\/Biohack_Blueprint, r\/Peptides at\u010f. pon\u00fakaj\u00fa pou\u017e\u00edvate\u013esk\u00e9 svedectv\u00e1 o tom, s \u010d\u00edm \u013eudia experimentovali. Po komplexnom presk\u00faman\u00ed sa n\u00e1m nepodarilo n\u00e1js\u0165 \u017eiadne konzistentne dobr\u00e9 d\u00e1vkovanie. V\u00fdzva je tu skuto\u010dn\u00e1 \u2013 \u013eudia jednoducho nevedia, ako extrapolova\u0165 FOXO4-DRI. Existuj\u00fa ojedinel\u00e9 podrobn\u00e9 sebaexperimenty, \u010dasto v\u0161ak ch\u00fdba ak\u00e9ko\u013evek spr\u00e1vne vykazovanie. Ve\u013ek\u00e1 \u010das\u0165 biohackingovej komunity v\u00e1ha s diskusiou o d\u00e1vkovan\u00ed FOXO4-DRI a mnoh\u00ed biohackeri pri ur\u010dovan\u00ed d\u00e1vok alebo kombinovan\u00ed FOXO4-DRI jednoducho prech\u00e1dzaj\u00fa k in\u00fdm peptidom.<\/span><\/p>\n<h2><span style=\"font-weight: 400;\">Pr\u00edprava a skladovanie<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Teraz prin\u00e1\u0161ame postup, ako pripravi\u0165 a uskladni\u0165 FOXO4-DRI na v\u00fdskumn\u00e9 \u00fa\u010dely:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pred\u00e1va sa ako lyofilizovan\u00fd pr\u00e1\u0161ok. Skladujte na chladnom a tmavom mieste pri izbovej teplote alebo v mraziacim boxe pri teplote -20 \u00b0C alebo ni\u017e\u0161ej. Zabr\u00e1\u0148te cyklom zmrazovania a rozmrazovania. Chr\u00e1\u0148te pred svetlom a vlhkos\u0165ou. \u010cas pou\u017eite\u013enosti je zvy\u010dajne 2 roky od v\u00fdroby. Po rekon\u0161tit\u00facii uchov\u00e1vajte roztok v chladni\u010dke pri teplote 2 \u2013 8 \u00b0C (vydr\u017e\u00ed pribli\u017ene 4 t\u00fd\u017edne).<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pred poru\u0161en\u00edm uz\u00e1veru nechajte zape\u010daten\u00fa injek\u010dn\u00fa liekovku zohria\u0165 na izbov\u00fa teplotu, aby na pr\u00e1\u0161ku nekondenzovala okolit\u00e1 vlhkos\u0165.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Riedidlo prid\u00e1vajte pomaly po vn\u00fatornej stene liekovky, nie priamo na pr\u00e1\u0161kov\u00fa, lyofilizovan\u00fa tabletku.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Mie\u0161anie. Jemne kr\u00fa\u017ete alebo nechajte vo\u013ene rozpusti\u0165 bez mie\u0161ania. Nikdy nepou\u017e\u00edvajte vortex ani pretrep\u00e1vanie. Mechanick\u00e9 \u0161mykov\u00e9 sily a penenie degraduj\u00fa dlh\u00e9 peptidy.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Rozde\u013ete na jednorazov\u00e9 objemy v bode rekon\u0161tit\u00facie, aby sa pracovn\u00e1 z\u00e1soba nikdy op\u00e4tovne nezmrazovala. Opakovan\u00e9 cykly zmrazovania a rozmrazovania s\u00fa hlavnou odstr\u00e1nite\u013enou pr\u00ed\u010dinou straty aktivity.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-weight: 400;\">\u010cast\u00e9 ot\u00e1zky k FOXO4-DRI<\/span><\/h2>\n<h3><span style=\"font-weight: 400;\">\u010co s\u00fa to senescuj\u00face bunky?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Zatknut\u00e9, ale \u017eij\u00face, st\u00e1le vylu\u010duj\u00face. Bunky, ktor\u00e9 sa v podstate dr\u017eia a odol\u00e1vaj\u00fa apoptoze.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">\u010co je to dr\u00e1ha FOXO4-p53 a pre\u010do je tu d\u00f4le\u017eit\u00e1?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">FOXO4 je prote\u00edn, ktor\u00fd sa via\u017ee na p53, \u010fal\u0161\u00ed prote\u00edn v bunke. Potom \u201cdr\u017e\u00ed\u201d p53 v jadre. To zabra\u0148uje p53 v presune do mitochondri\u00ed a vyslaniu sign\u00e1lu na apopt\u00f3zu (bunkov\u00fa samovra\u017edu). Takto starn\u00face bunky odol\u00e1vaj\u00fa smrti, aj ke\u010f sa u\u017e nedelia a s\u00fa pripraven\u00e9 zomrie\u0165.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Bolo FOXO4-DRI testovan\u00e9 na \u013eu\u010foch?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Nie. V\u00fdvoj\u00e1rska spolo\u010dnos\u0165 a p\u00f4vodn\u00e9 laborat\u00f3rium sa taktie\u017e presunuli k zl\u00fa\u010denin\u00e1m novej gener\u00e1cie so zlep\u0161en\u00fdm bezpe\u010dnostn\u00fdm profilom.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Ako sa to l\u00ed\u0161i od peror\u00e1lnych senolyt\u00edk, ako s\u00fa fiset\u00edn alebo kvercet\u00edn?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">In\u00fd mechanizmus, in\u00fd sp\u00f4sob pod\u00e1vania a na rozdiel od nich \u017eiadne \u00fadaje z klinick\u00fdch sk\u00fa\u0161ok na \u013eu\u010foch. Pozrite si \u010das\u0165 \u201cFOXO4-DRI vs. in\u00e9 senolytik\u00e1\u201d vy\u0161\u0161ie.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Pre\u010do je selektivita v\u00fdskumnou ot\u00e1zkou a nie vyrie\u0161en\u00fdm faktom?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Preto\u017ee to z\u00e1vis\u00ed od zv\u00fd\u0161enej hladiny FOXO4 v senescentn\u00fdch buniek a n\u00edzkej inde, preto\u017ee sa zd\u00e1, \u017ee niektor\u00e9 popul\u00e1cie senescentn\u00fdch buniek plnia ochrann\u00e9 funkcie, a preto\u017ee najmenej jedna \u0161t\u00fadia zistila, \u017ee senolytick\u00e9 odstr\u00e1nenie zhor\u0161ilo v\u00fdsledky v \u0161pecifickom cievnom kontexte.<\/span><\/p>\n<h3><span style=\"font-weight: 400;\">Na \u010do je tento produkt ur\u010den\u00fd?<\/span><\/h3>\n<p><span style=\"font-weight: 400;\">Len na laborat\u00f3rne v\u00fdskumn\u00e9 \u00fa\u010dely. Nie je ur\u010den\u00e9 na \u013eudsk\u00e9 ani veterin\u00e1rne pou\u017eitie, nie je to v\u00fd\u017eivov\u00fd doplnok, nie je to liek, nie je ur\u010den\u00e9 na diagnostick\u00e9 ani terapeutick\u00e9 pou\u017eitie.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">\u0160t\u00fadie<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Cielen\u00e1 apoptoza senescentn\u00fdch buniek obnovuje tkanivov\u00fa homeost\u00e1zu v reakcii na chemotoxicitu a starnutie <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28340339\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/28340339\/\u00a0<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Odstr\u00e1nenie senescentn\u00fdch buniek pozit\u00edvnych na p16Ink4a oddituje poruchy spojen\u00e9 so starnut\u00edm <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22048312\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/22048312\/\u00a0<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Sekre\u010dn\u00fd fenotyp s\u00favisiaci so senescenciou: temn\u00e1 str\u00e1nka supresie n\u00e1dorov \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20078217\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/20078217\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">FOXO4-DRI zmier\u0148uje nedostato\u010dnos\u0165 sekr\u00e9cie testoster\u00f3nu s\u00favisiacu s vekom zameran\u00edm sa na senescentn\u00e9 Leydigove bunky u star\u00fdch my\u0161\u00ed <a href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7053614\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7053614\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Senolytick\u00fd peptid FOXO4-DRI selekt\u00edvne odstra\u0148uje senescentn\u00e9 bunky z in vitro expandovan\u00fdch \u013eudsk\u00fdch chondrocytov <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33996787\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/33996787\/\u00a0<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Peptid FOXO4 zameran\u00fd na myofibroblasty zlep\u0161uje p\u013e\u00facnu fibr\u00f3zu vyvolan\u00fa bleomycinom u my\u0161\u00ed prostredn\u00edctvom dr\u00e1hy interakcie ECM-receptor <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35510614\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35510614\/\u00a0<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">FOXO4-DRI zlep\u0161uje spermatogen\u00e9zu u star\u00fdch my\u0161\u00ed prostredn\u00edctvom zn\u00ed\u017eenia sekr\u00e9cie fenotypu spojen\u00e9ho so senescenciou z Leydigov\u00fdch buniek<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/39025385\/\" target=\"_blank\" rel=\"noopener\"> https:\/\/pubmed.ncbi.nlm.nih.gov\/39025385\/<\/a><\/span><\/p>\n<p><span style=\"font-weight: 400;\">FOXO4-DRI reguluje senescenciu endotelov\u00fdch buniek prostredn\u00edctvom sign\u00e1lnej dr\u00e1hy P53 \u2013 <a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/41625068\/\" target=\"_blank\" rel=\"noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/41625068\/\u00a0<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"<p><span style=\"font-weight: 400;\"><strong>FOXO4<\/strong> je prote\u00edn, ktor\u00fd sa via\u017ee na p53 vn\u00fatri bunky, \u010d\u00edm blokuje sign\u00e1ly podporuj\u00face smr\u0165 v starn\u00facich (senescentn\u00fdch) bunk\u00e1ch. To efekt\u00edvne br\u00e1ni starn\u00facim bunk\u00e1m v umieran\u00ed. Po naviazan\u00ed FOXO4 zabra\u0148uje p53 uvo\u013e\u0148ova\u0165 sign\u00e1ly ako BAX, ktor\u00e9 by viedli k bunkovej samovra\u017ede (apopt\u00f3ze). <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Ak by ste v\u0161ak dok\u00e1zali t\u00fato v\u00e4zbu preru\u0161i\u0165, bunka je teraz vo\u013en\u00e1 a m\u00f4\u017ee uvo\u013eni\u0165 sign\u00e1ly predur\u010duj\u00face smr\u0165 bunky. FOXO4-DRI je peptid, ktor\u00fd rob\u00ed presne to \u2013 preru\u0161uje t\u00fato v\u00e4zbu. To n\u00e1sledne sp\u00f4sob\u00ed, \u017ee p53 sa presunie von z jadra, \u010d\u00edm sa starn\u00face bunky efekt\u00edvne usmrtia. Z tohto d\u00f4vodu sa FOXO4-DRI sk\u00fama pre svoje \u00fa\u010dinky proti starnutiu u my\u0161\u00ed (\u00fadaje z klinick\u00fdch \u0161t\u00fadi\u00ed s \u013eu\u010fmi neexistuj\u00fa).<\/span><\/p>","protected":false},"featured_media":15060,"template":"","meta":{"_acf_changed":false,"ub_ctt_via":""},"product_brand":[],"product_cat":[52,46,54],"product_tag":[],"class_list":["post-15058","product","type-product","status-publish","has-post-thumbnail","product_cat-anti-inflammatory-response-research-peptides","product_cat-peptides-for-longevity-research","product_cat-peptides-for-tissue-healing-research","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Buy FOXO4-DRI 2mg (99% Purity) - CellPeptides<\/title>\n<meta name=\"description\" content=\"Buy FOXO4-DRI for senescence and longevity research, 99% purity, HPLC-tested. Click here to check availability and order today.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cellpeptides.com\/sk\/product\/buy-tesamorelin-5mg\/\" \/>\n<meta property=\"og:locale\" content=\"sk_SK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Buy FOXO4-DRI 2mg (99% Purity) - CellPeptides\" \/>\n<meta property=\"og:description\" content=\"Buy FOXO4-DRI for senescence and longevity research, 99% purity, HPLC-tested. Click here to check availability and order today.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cellpeptides.com\/sk\/product\/buy-tesamorelin-5mg\/\" \/>\n<meta property=\"og:site_name\" content=\"CellPeptides\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-12T10:25:58+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Predpokladan\u00fd \u010das \u010d\u00edtania\" \/>\n\t<meta name=\"twitter:data1\" content=\"10 min\u00fat\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-foxo4-dri-2mg\/\",\"url\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/\",\"name\":\"Buy FOXO4-DRI 2mg (99% Purity) - CellPeptides\",\"isPartOf\":{\"@id\":\"https:\/\/cellpeptides.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png\",\"datePublished\":\"2026-08-12T10:09:36+00:00\",\"dateModified\":\"2026-08-12T10:25:58+00:00\",\"description\":\"Buy FOXO4-DRI for senescence and longevity research, 99% purity, HPLC-tested. Click here to check availability and order today.\",\"breadcrumb\":{\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#breadcrumb\"},\"inLanguage\":\"sk-SK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png\",\"width\":1200,\"height\":1200,\"caption\":\"FOXO4-DRI 2mg_mockup\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cellpeptides.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\/\/cellpeptides.com\/shop\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"FOXO4-DRI 2mg\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cellpeptides.com\/#website\",\"url\":\"https:\/\/cellpeptides.com\/\",\"name\":\"CellPeptides\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cellpeptides.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cellpeptides.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"sk-SK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cellpeptides.com\/#organization\",\"name\":\"CellPeptides\",\"url\":\"https:\/\/cellpeptides.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sk-SK\",\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"contentUrl\":\"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png\",\"width\":697,\"height\":152,\"caption\":\"CellPeptides\"},\"image\":{\"@id\":\"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"K\u00fapi\u0165 FOXO4-DRI 2 mg (\u010distota 99%) \u2013 CellPeptides","description":"K\u00fapte si FOXO4-DRI na v\u00fdskum starnutia a dlhovekosti, \u010distota 99%, testovan\u00e9 met\u00f3dou HPLC. Kliknite sem, aby ste si overili dostupnos\u0165 a objednali e\u0161te dnes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cellpeptides.com\/sk\/product\/buy-tesamorelin-5mg\/","og_locale":"sk_SK","og_type":"article","og_title":"Buy FOXO4-DRI 2mg (99% Purity) - CellPeptides","og_description":"Buy FOXO4-DRI for senescence and longevity research, 99% purity, HPLC-tested. Click here to check availability and order today.","og_url":"https:\/\/cellpeptides.com\/sk\/product\/buy-tesamorelin-5mg\/","og_site_name":"CellPeptides","article_modified_time":"2026-08-12T10:25:58+00:00","og_image":[{"width":1200,"height":1200,"url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Predpokladan\u00fd \u010das \u010d\u00edtania":"10 min\u00fat"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cellpeptides.com\/product\/buy-foxo4-dri-2mg\/","url":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/","name":"K\u00fapi\u0165 FOXO4-DRI 2 mg (\u010distota 99%) \u2013 CellPeptides","isPartOf":{"@id":"https:\/\/cellpeptides.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage"},"image":{"@id":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage"},"thumbnailUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png","datePublished":"2026-08-12T10:09:36+00:00","dateModified":"2026-08-12T10:25:58+00:00","description":"K\u00fapte si FOXO4-DRI na v\u00fdskum starnutia a dlhovekosti, \u010distota 99%, testovan\u00e9 met\u00f3dou HPLC. Kliknite sem, aby ste si overili dostupnos\u0165 a objednali e\u0161te dnes.","breadcrumb":{"@id":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#breadcrumb"},"inLanguage":"sk-SK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/"]}]},{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#primaryimage","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2026\/08\/FOXO4-DRI-2mg_mockup.png","width":1200,"height":1200,"caption":"FOXO4-DRI 2mg_mockup"},{"@type":"BreadcrumbList","@id":"https:\/\/cellpeptides.com\/product\/buy-tesamorelin-5mg\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cellpeptides.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/cellpeptides.com\/shop\/"},{"@type":"ListItem","position":3,"name":"FOXO4-DRI 2mg"}]},{"@type":"WebSite","@id":"https:\/\/cellpeptides.com\/#website","url":"https:\/\/cellpeptides.com\/","name":"CellPeptides","description":"","publisher":{"@id":"https:\/\/cellpeptides.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cellpeptides.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"sk-SK"},{"@type":"Organization","@id":"https:\/\/cellpeptides.com\/#organization","name":"CellPeptides","url":"https:\/\/cellpeptides.com\/","logo":{"@type":"ImageObject","inLanguage":"sk-SK","@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/","url":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","contentUrl":"https:\/\/cellpeptides.com\/wp-content\/uploads\/2025\/02\/CellPeptides-logo2-lc2.png","width":697,"height":152,"caption":"CellPeptides"},"image":{"@id":"https:\/\/cellpeptides.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product\/15058","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/types\/product"}],"version-history":[{"count":0,"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product\/15058\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/media\/15060"}],"wp:attachment":[{"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/media?parent=15058"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product_brand?post=15058"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product_cat?post=15058"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cellpeptides.com\/sk\/wp-json\/wp\/v2\/product_tag?post=15058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}